LivingGLP1
Study S000659

Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia.

Registration

Registration
NCT04969627
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
COMPLETED
Enrollment
60
Start
2021-01-04
Primary completion
2022-01-04
Lead sponsor
Bing He
Conditions
Polycystic Ovary Syndrome
Interventions
DRUG:Metformin; DRUG:Exenatide
Results posted
FALSE

Registered primary outcomes

  • Change in body weight [12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.